Boston Scientific Acquires Tumor Surgery Technology

New England Council member Boston Scientific recently acquired a medical device that improves endoscopic surgery for precancerous tumors.

Boston Scientific purchased the LumenR Tissue Retractor System from LumenR LCC. The system can make endoscopic submucosal dissection and endoscopic mucosal resection easier and faster, leading to better care for patients. It improves visualizations of lesions, making it easier for surgeons to complete the procedures.

“We are excited about the potential of the LumenR system to improve visibility and control during ESD and EMR procedures and improve quality of life for patients,” said Art Butcher, senior vice president and president, endoscopy. “Every year, patients around the world undergo open gastrointestinal surgery that has a profound impact on their lives. By bringing this innovative technology forward, we have an opportunity for more physicians to treat patients successfully through less invasive endoscopic procedures.”

The New England Council congratulates Boston Scientific on the acquisition and for continuing to innovate in healthcare. Read more in the press release and the Worcester Business Journal.

img_side
mask_sidebar
Recently from the Blog

Dean College President Rooney Honored by Indiana Univeristy

02/22/2021 | Read Post

Environmental Experts Discuss 2021 Federal Policy Outlook

02/2/2021 | Read Post

In the News

NEC Elects Six Respected Regional Business Leaders to Board of Directors

09/28/2020 | Read Press Release

NEC Announces 2020 New Englanders of the Year

08/25/2020 | Read Press Release